No connection

Search Results

MGNX vs OSUR

MGNX
MacroGenics, Inc.
BEARISH
Price
$3.47
Market Cap
$220.6M
Sector
Healthcare
AI Confidence
85%
OSUR
OraSure Technologies, Inc.
BEARISH
Price
$3.24
Market Cap
$224.0M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
MGNX
--
OSUR
--
Forward P/E
MGNX
-3.58
OSUR
-6.89
P/B Ratio
MGNX
3.95
OSUR
0.67
P/S Ratio
MGNX
1.48
OSUR
1.95
EV/EBITDA
MGNX
-1.03
OSUR
-0.66

Profitability

Gross Margin
MGNX
-22.53%
OSUR
41.9%
Operating Margin
MGNX
-29.34%
OSUR
-61.1%
Profit Margin
MGNX
-49.91%
OSUR
-59.76%
ROE
MGNX
-86.94%
OSUR
-18.3%
ROA
MGNX
-17.56%
OSUR
-9.57%

Growth

Revenue Growth
MGNX
113.0%
OSUR
-28.5%
Earnings Growth
MGNX
--
OSUR
--

Financial Health

Debt/Equity
MGNX
0.66
OSUR
0.04
Current Ratio
MGNX
5.1
OSUR
6.58
Quick Ratio
MGNX
4.71
OSUR
5.57

Dividends

Dividend Yield
MGNX
--
OSUR
--
Payout Ratio
MGNX
0.0%
OSUR
0.0%

AI Verdict

MGNX BEARISH

MGNX exhibits critical fundamental weakness, highlighted by a Piotroski F-Score of 0/9, indicating severe deterioration across all financial health dimensions. While the company shows explosive revenue growth (113% YoY) and maintains a strong liquidity position (Current Ratio 5.10), it suffers from negative gross margins and a consistent track record of missing earnings estimates. The recent 1-year price surge appears decoupled from fundamental value, as the company remains deeply unprofitable with a catastrophic ROE of -86.94%.

Strengths
Exceptional YoY revenue growth of 113%
Strong short-term liquidity with a Current Ratio of 5.10
Manageable Debt/Equity ratio of 0.66
Risks
Critical fundamental health (Piotroski F-Score 0/9)
Negative gross margins (-22.53%) indicating an unsustainable cost structure
Severe earnings volatility and frequent misses (Average surprise -286.67%)
OSUR BEARISH

OSUR presents a stark contrast between a fortress-like balance sheet and a deteriorating business model. While the Piotroski F-Score of 6/9 indicates stable financial health and the company maintains exceptional liquidity (Current Ratio 6.58) with negligible debt, the operational metrics are alarming. Revenue has contracted by 28.5% YoY, and profit margins are deeply negative at -59.76%. Despite trading at a significant discount to book value (P/B 0.67), the lack of growth and consistent earnings misses suggest a value trap.

Strengths
Extremely low Debt/Equity ratio (0.04)
Exceptional liquidity with a Current Ratio of 6.58
Trading below book value (P/B 0.67)
Risks
Severe revenue contraction (-28.5% YoY)
Deeply negative profit and operating margins
Consistent failure to meet earnings estimates in recent quarters

Compare Another Pair

MGNX vs OSUR: Head-to-Head Comparison

This page compares MacroGenics, Inc. (MGNX) and OraSure Technologies, Inc. (OSUR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile